Beckman Coulter Diagnostics appoints Catherine Jennings as president
Bitget2026/10/14 12:33- Danaher unit Beckman Coulter Diagnostics appointed Catherine “Cat” Jennings as president.
- Jennings will oversee strategy and operations, with a mandate to accelerate innovation and expand global reach in clinical diagnostics.
- She joins from Boston Scientific, where she led the Vascular Therapies business, a unit with about USD 2 billion annual revenue.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Korean retail investors start bottom fishing! Their targets are still "Samsung and SK Hynix leveraged ETFs"
Amid a sharp drop in Korean stocks, Korean retail investors turned contrarian, making a net purchase of over 315.4 billion KRW in leveraged products of Samsung and SK Hynix in October alone. They simultaneously spent 4.7 trillion KRW acquiring US-listed triple-leveraged semiconductor ETF (SOXL), accounting for nearly 74% of total purchases of US stocks during the same period. This marks the first rebound since tightening regulations in July and two consecutive months of net selling.